Tarun Singhal, M.B.,B.S., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Positron-Emission Tomography | 23 | 2024 | 6483 | 2.720 |
Why?
|
Multiple Sclerosis | 6 | 2024 | 3222 | 1.320 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 3 | 2021 | 254 | 1.300 |
Why?
|
Putamen | 2 | 2022 | 292 | 1.250 |
Why?
|
Neuroglia | 2 | 2024 | 954 | 1.090 |
Why?
|
Acetanilides | 3 | 2021 | 169 | 0.970 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 2 | 2019 | 556 | 0.810 |
Why?
|
Microglia | 3 | 2023 | 1357 | 0.810 |
Why?
|
Demyelinating Autoimmune Diseases, CNS | 1 | 2022 | 38 | 0.780 |
Why?
|
Meningitis, Aseptic | 1 | 2021 | 59 | 0.750 |
Why?
|
Fluorodeoxyglucose F18 | 4 | 2020 | 2008 | 0.720 |
Why?
|
Radiopharmaceuticals | 8 | 2019 | 2650 | 0.710 |
Why?
|
Mesencephalon | 1 | 2022 | 333 | 0.680 |
Why?
|
Septum of Brain | 1 | 2019 | 18 | 0.670 |
Why?
|
Meningitis, Bacterial | 3 | 2013 | 221 | 0.670 |
Why?
|
Encephalitis, Herpes Simplex | 1 | 2019 | 65 | 0.640 |
Why?
|
Fluorine Radioisotopes | 2 | 2019 | 418 | 0.630 |
Why?
|
Substantia Nigra | 1 | 2020 | 350 | 0.620 |
Why?
|
Encephalitis | 1 | 2022 | 438 | 0.600 |
Why?
|
Methionine | 2 | 2012 | 572 | 0.590 |
Why?
|
Receptors, GABA | 2 | 2022 | 313 | 0.550 |
Why?
|
Alzheimer Disease | 4 | 2023 | 8603 | 0.460 |
Why?
|
Nervous System Diseases | 2 | 2016 | 1662 | 0.450 |
Why?
|
Movement Disorders | 2 | 2014 | 459 | 0.430 |
Why?
|
Meningocele | 1 | 2013 | 47 | 0.430 |
Why?
|
Nuclear Medicine | 1 | 2016 | 237 | 0.430 |
Why?
|
Fatigue | 1 | 2020 | 1550 | 0.430 |
Why?
|
Encephalocele | 1 | 2013 | 135 | 0.400 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2022 | 2872 | 0.380 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2016 | 1068 | 0.380 |
Why?
|
Spinal Cord | 2 | 2016 | 1807 | 0.370 |
Why?
|
Huntington Disease | 1 | 2017 | 1144 | 0.350 |
Why?
|
Neuroprotective Agents | 1 | 2016 | 957 | 0.330 |
Why?
|
Cephalosporins | 2 | 2007 | 198 | 0.320 |
Why?
|
Brain | 11 | 2023 | 27100 | 0.300 |
Why?
|
Epilepsy | 3 | 2023 | 3303 | 0.260 |
Why?
|
Inflammation | 2 | 2024 | 10759 | 0.260 |
Why?
|
Cerebral Cortex | 1 | 2022 | 5776 | 0.250 |
Why?
|
Glioma | 2 | 2012 | 3452 | 0.250 |
Why?
|
Islets of Langerhans | 1 | 2010 | 1340 | 0.230 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2010 | 1117 | 0.230 |
Why?
|
Dementia | 2 | 2014 | 2686 | 0.210 |
Why?
|
Carbon Radioisotopes | 3 | 2014 | 561 | 0.200 |
Why?
|
Brain Neoplasms | 3 | 2014 | 9026 | 0.190 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2016 | 10203 | 0.190 |
Why?
|
Magnetic Resonance Imaging | 9 | 2022 | 36401 | 0.190 |
Why?
|
Multiple System Atrophy | 1 | 2022 | 130 | 0.180 |
Why?
|
Vesico-Ureteral Reflux | 1 | 2004 | 437 | 0.170 |
Why?
|
Contrast Media | 1 | 2012 | 5305 | 0.160 |
Why?
|
Diagnostic Imaging | 1 | 2013 | 3527 | 0.160 |
Why?
|
Humans | 35 | 2024 | 760740 | 0.160 |
Why?
|
Acyclovir | 1 | 2019 | 267 | 0.150 |
Why?
|
Middle Aged | 14 | 2024 | 220603 | 0.150 |
Why?
|
Fatal Outcome | 2 | 2019 | 1835 | 0.140 |
Why?
|
Infusions, Intravenous | 1 | 2021 | 2214 | 0.130 |
Why?
|
Female | 17 | 2024 | 392203 | 0.130 |
Why?
|
Adult | 12 | 2024 | 220995 | 0.130 |
Why?
|
Status Epilepticus | 1 | 2020 | 461 | 0.120 |
Why?
|
Pilot Projects | 2 | 2019 | 8619 | 0.120 |
Why?
|
Male | 13 | 2024 | 360402 | 0.110 |
Why?
|
Vaccines | 1 | 2022 | 838 | 0.110 |
Why?
|
Activities of Daily Living | 1 | 2023 | 2419 | 0.110 |
Why?
|
Autoantibodies | 1 | 2022 | 2115 | 0.110 |
Why?
|
Ethylenediamines | 1 | 2003 | 57 | 0.110 |
Why?
|
Neurodegenerative Diseases | 1 | 2022 | 1085 | 0.110 |
Why?
|
Technetium | 1 | 2003 | 317 | 0.100 |
Why?
|
Naphthols | 1 | 2012 | 46 | 0.100 |
Why?
|
Limbic Encephalitis | 1 | 2012 | 36 | 0.100 |
Why?
|
Adenovirus Infections, Human | 1 | 2012 | 73 | 0.100 |
Why?
|
Anti-Bacterial Agents | 2 | 2007 | 7403 | 0.100 |
Why?
|
Receptors, Dopamine D3 | 1 | 2012 | 108 | 0.090 |
Why?
|
Atrophy | 1 | 2016 | 1632 | 0.090 |
Why?
|
Organ Size | 1 | 2016 | 2252 | 0.090 |
Why?
|
Obesity, Morbid | 1 | 2022 | 1276 | 0.090 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2022 | 1851 | 0.090 |
Why?
|
Rats, Zucker | 1 | 2010 | 131 | 0.090 |
Why?
|
Chloramphenicol | 2 | 2007 | 67 | 0.090 |
Why?
|
Streptozocin | 1 | 2010 | 193 | 0.090 |
Why?
|
Benzoxazines | 1 | 2012 | 316 | 0.090 |
Why?
|
Central Nervous System Diseases | 1 | 2014 | 521 | 0.090 |
Why?
|
Ampicillin | 2 | 2007 | 136 | 0.090 |
Why?
|
Receptor, Serotonin, 5-HT1B | 1 | 2009 | 36 | 0.090 |
Why?
|
Feasibility Studies | 1 | 2021 | 5239 | 0.090 |
Why?
|
Norepinephrine Plasma Membrane Transport Proteins | 1 | 2010 | 66 | 0.090 |
Why?
|
Oxazines | 1 | 2012 | 349 | 0.080 |
Why?
|
Receptors, Dopamine D2 | 1 | 2012 | 484 | 0.080 |
Why?
|
Dopamine Agonists | 1 | 2012 | 352 | 0.080 |
Why?
|
Catatonia | 1 | 2012 | 178 | 0.080 |
Why?
|
Electroencephalography | 2 | 2022 | 6240 | 0.080 |
Why?
|
Pyrrolidinones | 1 | 2009 | 116 | 0.080 |
Why?
|
Sarcoidosis | 1 | 2014 | 520 | 0.080 |
Why?
|
Parkinson Disease | 1 | 2022 | 2878 | 0.080 |
Why?
|
Penicillins | 2 | 2007 | 402 | 0.070 |
Why?
|
Antiviral Agents | 1 | 2019 | 3037 | 0.070 |
Why?
|
Aged | 6 | 2023 | 169092 | 0.070 |
Why?
|
Morpholines | 1 | 2010 | 581 | 0.070 |
Why?
|
Cocaine-Related Disorders | 1 | 2010 | 461 | 0.070 |
Why?
|
Propofol | 1 | 2012 | 602 | 0.070 |
Why?
|
Pyrimidines | 1 | 2018 | 3027 | 0.070 |
Why?
|
Community-Acquired Infections | 2 | 2007 | 469 | 0.070 |
Why?
|
Radionuclide Imaging | 2 | 2004 | 1972 | 0.060 |
Why?
|
Organophosphorus Compounds | 1 | 2006 | 206 | 0.060 |
Why?
|
Hypnotics and Sedatives | 1 | 2012 | 1178 | 0.060 |
Why?
|
Hypertension | 1 | 2004 | 8532 | 0.060 |
Why?
|
Retrospective Studies | 4 | 2022 | 80583 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2016 | 8998 | 0.050 |
Why?
|
Disease Progression | 1 | 2020 | 13495 | 0.050 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2006 | 370 | 0.050 |
Why?
|
Organometallic Compounds | 1 | 2006 | 646 | 0.050 |
Why?
|
Animals | 6 | 2022 | 168202 | 0.050 |
Why?
|
Intermediate Filaments | 1 | 2022 | 171 | 0.050 |
Why?
|
Antigens, CD20 | 1 | 2022 | 199 | 0.050 |
Why?
|
Recurrence | 1 | 2013 | 8426 | 0.050 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2022 | 550 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2022 | 39062 | 0.040 |
Why?
|
Neurofilament Proteins | 1 | 2022 | 333 | 0.040 |
Why?
|
Acute Disease | 2 | 2007 | 7236 | 0.040 |
Why?
|
Autopsy | 1 | 2022 | 1008 | 0.040 |
Why?
|
Piperazines | 1 | 2009 | 2521 | 0.040 |
Why?
|
Amyloid | 1 | 2023 | 841 | 0.040 |
Why?
|
Kidney Transplantation | 1 | 2003 | 4218 | 0.040 |
Why?
|
Adolescent | 3 | 2022 | 88247 | 0.030 |
Why?
|
alpha-Synuclein | 1 | 2022 | 752 | 0.030 |
Why?
|
Insulin | 1 | 2010 | 6593 | 0.030 |
Why?
|
Young Adult | 1 | 2022 | 59191 | 0.030 |
Why?
|
Rats | 1 | 2010 | 23716 | 0.030 |
Why?
|
Bone Neoplasms | 1 | 2006 | 2527 | 0.030 |
Why?
|
Kidney Tubular Necrosis, Acute | 1 | 2003 | 65 | 0.030 |
Why?
|
Kidney | 2 | 2022 | 7044 | 0.030 |
Why?
|
Leukemia, Prolymphocytic, T-Cell | 1 | 2012 | 23 | 0.030 |
Why?
|
Prognosis | 1 | 2012 | 29601 | 0.020 |
Why?
|
Herpesvirus 6, Human | 1 | 2012 | 96 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2022 | 3149 | 0.020 |
Why?
|
Pain | 1 | 2006 | 5062 | 0.020 |
Why?
|
Palliative Care | 1 | 2006 | 3593 | 0.020 |
Why?
|
Weight Loss | 1 | 2022 | 2682 | 0.020 |
Why?
|
Binding, Competitive | 1 | 2012 | 1141 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3370 | 0.020 |
Why?
|
Psychomotor Agitation | 1 | 2012 | 305 | 0.020 |
Why?
|
Electron Spin Resonance Spectroscopy | 1 | 2009 | 162 | 0.020 |
Why?
|
Comorbidity | 1 | 2004 | 10507 | 0.020 |
Why?
|
Amyloid beta-Peptides | 1 | 2023 | 3839 | 0.020 |
Why?
|
Aging | 2 | 2022 | 8700 | 0.020 |
Why?
|
Tacrolimus | 1 | 2012 | 733 | 0.020 |
Why?
|
Dopamine Uptake Inhibitors | 1 | 2010 | 297 | 0.020 |
Why?
|
Isotope Labeling | 1 | 2009 | 392 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2012 | 1790 | 0.020 |
Why?
|
Seizures | 1 | 2020 | 2964 | 0.020 |
Why?
|
Prevalence | 1 | 2004 | 15702 | 0.020 |
Why?
|
Immunocompromised Host | 1 | 2012 | 858 | 0.020 |
Why?
|
Benzodiazepines | 1 | 2012 | 1133 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2009 | 1540 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2014 | 1878 | 0.020 |
Why?
|
Macaca mulatta | 1 | 2012 | 2328 | 0.020 |
Why?
|
Cocaine | 1 | 2010 | 958 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2012 | 2690 | 0.010 |
Why?
|
Child | 1 | 2012 | 80089 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2003 | 4802 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2004 | 26065 | 0.010 |
Why?
|
Anxiety Disorders | 1 | 2012 | 2724 | 0.010 |
Why?
|
China | 1 | 2006 | 2374 | 0.010 |
Why?
|
Graft Rejection | 1 | 2003 | 4438 | 0.010 |
Why?
|
Linear Models | 1 | 2009 | 5866 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2012 | 12966 | 0.010 |
Why?
|
Models, Statistical | 1 | 2009 | 5074 | 0.010 |
Why?
|
Mental Disorders | 1 | 2009 | 6826 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2006 | 58919 | 0.000 |
Why?
|
Neoplasms | 1 | 2006 | 22131 | 0.000 |
Why?
|